Arcturus Therapeutics Holdings (ARCT) Net Equity Issued and Repurchased (2020 - 2025)

Arcturus Therapeutics Holdings (ARCT) posted Net Equity Issued and Repurchased of $11.7 million for Q4 2025, down 92.77% on a QoQ basis from $161.9 million in Q4 2020.

Arcturus Therapeutics Holdings (ARCT) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends

Arcturus Therapeutics Holdings' Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $11.7 million for Q4 2025.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $11.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $360.0 million (changed N/A YoY) and the FY2025 annual result came in at $11.7 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased was $11.7 million for Q4 2025 at Arcturus Therapeutics Holdings, down from $161.9 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $11.7 million in Q4 2025 and bottomed at $11.7 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Arcturus Therapeutics Holdings 164.57 Mn -46.81 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 11.70 Mn
Dec 31, 2025 11.70 Mn
Dec 31, 2020 161.94 Mn
Dec 31, 2020 161.94 Mn
Sep 30, 2020 186.58 Mn
Sep 30, 2020 186.58 Mn
Jun 30, 2020 -195,000.00
Jun 30, 2020 -195,000.00